---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-020464"
form_type: "8-K"
ticker: "PLSE"
cik: "0001625101"
company_name: "PULSE BIOSCIENCES, INC."
filed_at: "2026-06-12T20:05:36+00:00"
generated_at: "2026-06-12T20:08:00.167915+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Pulse Biosciences stockholders elect all seven director nominees and ratify Deloitte as auditor

## Summary
- All seven director nominees were elected with overwhelming support (e.g., Robert W. Duggan 33.4M for vs. 1.6M against).
- Ratification of Deloitte & Touche LLP as independent auditor for FY 2026 passed with 45,976,355 votes for, 8,265 against.
- Meeting held virtually on June 11, 2026; results reflect routine annual meeting procedural votes.

## SEC filing metadata
- accession: 0001437749-26-020464
- form_type: 8-K
- ticker: PLSE
- cik: 0001625101
- company_name: PULSE BIOSCIENCES, INC.
- filed_at: 2026-06-12T20:05:36+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1625101/000143774926020464/0001437749-26-020464-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1625101/000143774926020464/plse20260607c_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-020464
- JSON: https://secwatch.observer/filing/0001437749-26-020464.json
- Plain text: https://secwatch.observer/filing/0001437749-26-020464.txt

## Key facts
- Shareholder Votes
  PULSE BIOSCIENCES, INC. shareholders approved Election of seven directors to hold office until the Company’s 2027 annual meeting and until their successors are duly elected and qualified at the 2026-06-11 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-06-11
  source text: 1. Election of Directors Nominee For Against Abstained Broker Non-votes Robert W. Duggan 33,443,582 1,583,174 388 10,974,550 Paul A. LaViolette 34,264,295 759,401 3,448 10,974,550 Maria Sainz 35,007,101 18,349 1,694 10,974,550 Manmeet S. Soni 33,560,875 1,464,574 1,695 10,974,550 Darrin R. Uecker 34,246,413 779,036 1,695 10,974,550 Richard A. van den Broek 34,278,978 746,471 1,695 10,974,550 Mahkam Zanganeh, D.D.S. 34,241,938 783,511 1,695 10,974,550 Each director nominee was duly elected
  evidence_url: https://www.sec.gov/Archives/edgar/data/1625101/000143774926020464/0001437749-26-020464-index.htm
- Shareholder Votes
  PULSE BIOSCIENCES, INC. shareholders approved Ratification of appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-11 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-06-11
  source text: 2. Ratification of Appointment of Independent Registered Public Accounting Firm For Against Abstained Broker Non-votes 45,976,355 8,265 17,074 N/A The stockholders ratified the appointment of Deloitte & Touche LLP
  evidence_url: https://www.sec.gov/Archives/edgar/data/1625101/000143774926020464/0001437749-26-020464-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.